| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B MYO9A MYO1H KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA DNAH17 KIF14 MACF1 ABCC2 ATP2B4 KIF11 | 5.21e-07 | 614 | 176 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA KIF14 MACF1 ABCC2 ATP2B4 | 1.94e-06 | 441 | 176 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RANGAP1 SPTAN1 OBSCN CKAP5 ITGAE EDIL3 CEMIP2 CNTN6 PTPN2 PTPN6 PTPN11 TLN1 EIF5 MACF1 CLINT1 DMD GCN1 UTRN | 6.14e-06 | 599 | 176 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.96e-06 | 118 | 176 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA SEPTIN14 SEPTIN11 KIF14 MACF1 GNAL GNAS ABCC2 ATP2B4 | 1.72e-05 | 775 | 176 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | actin filament binding | 3.46e-05 | 227 | 176 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 3.65e-05 | 8 | 176 | 3 | GO:0015431 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | VIL1 HIP1 MYO5B MYO9A MYO1H KIF21A SPTAN1 CEP290 OBSCN CKAP5 CLASP2 ADGRV1 LMOD2 RHO LRPPRC TLN1 KIF14 MACF1 RP1 GNAS DMD MAP4K4 UTRN KIF11 | 3.69e-05 | 1099 | 176 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA SEPTIN14 SEPTIN11 KIF14 MACF1 GNAL GNAS ABCC2 ATP2B4 | 5.27e-05 | 839 | 176 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA SEPTIN14 SEPTIN11 KIF14 MACF1 GNAL GNAS ABCC2 ATP2B4 | 5.36e-05 | 840 | 176 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 ATP6V1A ATP13A4 DNAH3 MYO5B KIF21A PSMC5 ABCC11 CHD8 CHD3 BLM MMAA SEPTIN14 SEPTIN11 KIF14 MACF1 GNAL GNAS ABCC2 ATP2B4 | 5.36e-05 | 840 | 176 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 7.72e-05 | 10 | 176 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine phosphatase activity | 1.40e-04 | 12 | 176 | 3 | GO:0004726 | |
| GeneOntologyMolecularFunction | vinculin binding | 1.80e-04 | 13 | 176 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | cadherin binding | RANGAP1 SPTAN1 OBSCN CKAP5 CEMIP2 PTPN11 TLN1 EIF5 MACF1 CLINT1 GCN1 | 2.18e-04 | 339 | 176 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.83e-04 | 15 | 176 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | actin binding | VIL1 HIP1 MYO5B MYO9A MYO1H SPTAN1 CLASP2 LMOD2 LRPPRC TLN1 MACF1 DMD UTRN | 3.39e-04 | 479 | 176 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.83e-04 | 70 | 176 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.12e-04 | 109 | 176 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | microtubule binding | KIF21A CEP290 CKAP5 CLASP2 LRPPRC KIF14 MACF1 RP1 MAP4K4 KIF11 | 4.20e-04 | 308 | 176 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 4.58e-04 | 4 | 176 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 4.58e-04 | 4 | 176 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 4.58e-04 | 4 | 176 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 4.58e-04 | 4 | 176 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.98e-04 | 18 | 176 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 6.87e-04 | 20 | 176 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | peptide hormone receptor binding | 7.97e-04 | 21 | 176 | 3 | GO:0051428 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 9.16e-04 | 22 | 176 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | acetylesterase activity | 1.13e-03 | 6 | 176 | 2 | GO:0008126 | |
| GeneOntologyMolecularFunction | phospholipid binding | VIL1 HIP1 PCLO OBSCN FABP1 ITPR1 TPCN1 UCP1 TLN1 OSBPL5 CLINT1 SDCBP2 GOT2 | 1.18e-03 | 548 | 176 | 13 | GO:0005543 |
| GeneOntologyMolecularFunction | tubulin binding | KIF21A CEP290 CKAP5 CLASP2 LRPPRC KIF14 MACF1 RP1 GNAS MAP4K4 KIF11 | 1.50e-03 | 428 | 176 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | dopamine receptor binding | 1.51e-03 | 26 | 176 | 3 | GO:0050780 | |
| GeneOntologyMolecularFunction | short-chain carboxylesterase activity | 1.58e-03 | 7 | 176 | 2 | GO:0034338 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | FLT1 RIPK3 HIPK4 MINK1 OBSCN POLRMT IRAK2 CDK11A PGM2L1 UCK1 NEK9 POLR3F TAMM41 PIK3CG CDK1 PPIP5K2 MAP4K4 DNTT | 1.63e-03 | 938 | 176 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | PDE6C MMAA GVINP1 SEPTIN14 UCP1 EIF2B2 EIF5 SEPTIN11 RP2 GNAL GNAS | 1.83e-03 | 439 | 176 | 11 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | PDE6C MMAA GVINP1 SEPTIN14 UCP1 EIF2B2 EIF5 SEPTIN11 RP2 GNAL GNAS | 1.83e-03 | 439 | 176 | 11 | GO:0019001 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.24e-03 | 151 | 176 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | clathrin binding | 2.32e-03 | 63 | 176 | 4 | GO:0030276 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.52e-03 | 31 | 176 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium ion binding | VIL1 DSG1 PCLO SPTAN1 ADGRV1 TBC1D8B EDIL3 PKDREJ RYR2 CEMIP2 ITPR1 MICU1 LRP1 MACF1 PCDH1 | 2.66e-03 | 749 | 176 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 2.67e-03 | 9 | 176 | 2 | GO:0004415 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.67e-03 | 9 | 176 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 2.67e-03 | 9 | 176 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | GTP binding | MMAA GVINP1 SEPTIN14 UCP1 EIF2B2 EIF5 SEPTIN11 RP2 GNAL GNAS | 2.82e-03 | 397 | 176 | 10 | GO:0005525 |
| GeneOntologyMolecularFunction | lipid binding | NPC1 VIL1 HIP1 PCLO OBSCN NR4A1 FABP12 FABP1 RHO ITPR1 TPCN1 LIPC UCP1 TLN1 OSBPL5 CLINT1 SDCBP2 GOT2 | 2.85e-03 | 988 | 176 | 18 | GO:0008289 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC3 ATP6V1A ATP13A4 ABCC11 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 KCNQ5 KCNQ4 UCP1 SCN8A ABCC2 ATP2B4 | 2.98e-03 | 758 | 176 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.02e-03 | 33 | 176 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 3.30e-03 | 34 | 176 | 3 | GO:0051427 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.30e-03 | 34 | 176 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 3.32e-03 | 10 | 176 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.47e-03 | 343 | 176 | 9 | GO:0005261 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating dopamine receptor signaling pathway | 3.45e-06 | 13 | 176 | 4 | GO:0007191 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 3.48e-06 | 141 | 176 | 9 | GO:0001952 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor-beta signaling pathway | 6.50e-06 | 15 | 176 | 4 | GO:0035791 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 9.73e-06 | 34 | 176 | 5 | GO:0007190 | |
| GeneOntologyBiologicalProcess | response to amine | 9.93e-06 | 58 | 176 | 6 | GO:0014075 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 1.10e-05 | 59 | 176 | 6 | GO:0045761 | |
| GeneOntologyBiologicalProcess | microtubule-based process | DNAH3 CHMP1B KIF21A CEP290 CKAP5 CDK11A CLASP2 CHD3 ADCY3 RHO LRPPRC NETO1 DNAH17 KIF14 MACF1 RP1 CDK1 GAPDHS SPAG16 CFAP44 ATP2B4 USP33 KIF11 CCDC40 | 1.18e-05 | 1058 | 176 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 1.20e-05 | 6 | 176 | 3 | GO:0043435 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 1.20e-05 | 6 | 176 | 3 | GO:0071376 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | CASS4 MINK1 CLASP2 ITGAE EDIL3 ADAMTS12 PTPN11 TLN1 LRP1 KIF14 MACF1 DMD MAP4K4 UTRN | 1.20e-05 | 410 | 176 | 14 | GO:0031589 |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | CASS4 MINK1 CLASP2 EDIL3 PTPN11 TLN1 LRP1 MACF1 DMD MAP4K4 UTRN | 1.22e-05 | 254 | 176 | 11 | GO:0010810 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | ATP6V1A FLT1 DRD1 COL11A1 PDE6C COMT NPEPPS NR4A2 CKAP5 ADGRV1 NR4A1 RRM1 PKDREJ KMO RYR2 FABP1 RHO ITPR1 MICU1 BLM PTPN11 NETO1 UCP1 EIF2B2 SWI5 RP1 DMD ATP2B4 | 1.27e-05 | 1361 | 176 | 28 | GO:0009628 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP6V1A ATP13A4 DRD1 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A DMD ABCC2 UTRN ATP2B4 NOS1AP | 1.30e-05 | 922 | 176 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP6V1A ATP13A4 DRD1 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A DMD ABCC2 UTRN ATP2B4 NOS1AP | 1.82e-05 | 942 | 176 | 22 | GO:0098655 |
| GeneOntologyBiologicalProcess | leukotriene transport | 2.08e-05 | 7 | 176 | 3 | GO:0071716 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | MINK1 CLASP2 ITGAE ADAMTS12 PTPN11 TLN1 LRP1 MACF1 DMD MAP4K4 UTRN | 2.15e-05 | 270 | 176 | 11 | GO:0007160 |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 2.21e-05 | 40 | 176 | 5 | GO:0045762 | |
| GeneOntologyBiologicalProcess | response to amphetamine | 2.21e-05 | 40 | 176 | 5 | GO:0001975 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 2.72e-05 | 69 | 176 | 6 | GO:0031279 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC3 ATP6V1A ATP13A4 DRD1 ABCC11 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A DMD ABCC2 UTRN ATP2B4 NOS1AP | 2.78e-05 | 1115 | 176 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of focal adhesion assembly | 2.96e-05 | 70 | 176 | 6 | GO:0051893 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction assembly | 2.96e-05 | 70 | 176 | 6 | GO:0090109 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 3.21e-05 | 71 | 176 | 6 | GO:0048008 | |
| GeneOntologyBiologicalProcess | regulation of platelet-derived growth factor receptor-beta signaling pathway | 3.31e-05 | 8 | 176 | 3 | GO:2000586 | |
| GeneOntologyBiologicalProcess | habituation | 3.31e-05 | 8 | 176 | 3 | GO:0046959 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | ATP13A4 DRD1 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 PIK3CG DMD ATP2B4 NOS1AP | 3.36e-05 | 392 | 176 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 3.76e-05 | 73 | 176 | 6 | GO:0051339 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 3.76e-05 | 73 | 176 | 6 | GO:0071869 | |
| GeneOntologyBiologicalProcess | response to monoamine | 4.06e-05 | 74 | 176 | 6 | GO:0071867 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 4.38e-05 | 75 | 176 | 6 | GO:0150116 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 4.90e-05 | 47 | 176 | 5 | GO:0045494 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 5.44e-05 | 48 | 176 | 5 | GO:0031281 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP6V1A ATP13A4 DRD1 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A DMD ABCC2 UTRN ATP2B4 NOS1AP | 5.74e-05 | 1017 | 176 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 6.01e-05 | 49 | 176 | 5 | GO:0051349 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | NPC1 DRD1 COMT NR4A3 PDIA3 ADCY3 RYR2 ITPR1 BLM PIK3CG UCP1 TAAR1 UGT3A2 GNAL CDK1 GNAS | 6.47e-05 | 605 | 176 | 16 | GO:0071407 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-cysteine S-nitrosylation | 9.58e-05 | 11 | 176 | 3 | GO:2000169 | |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid metabolic process | 1.01e-04 | 87 | 176 | 6 | GO:0170041 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP13A4 DRD1 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG SCN8A GNAS DMD ABCC2 UTRN ATP2B4 NOS1AP | 1.30e-04 | 1000 | 176 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6V1A ATP13A4 DRD1 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A GNAS DMD ABCC2 UTRN ATP2B4 NOS1AP | 1.37e-04 | 1157 | 176 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.55e-04 | 179 | 176 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | nonassociative learning | 1.64e-04 | 13 | 176 | 3 | GO:0046958 | |
| GeneOntologyBiologicalProcess | muscle contraction | FLT1 DRD1 NR4A1 IRAG1 LMOD2 RYR2 PIK3CG SCN8A DMD UTRN ATP2B4 NOS1AP | 1.74e-04 | 400 | 176 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 1.84e-04 | 97 | 176 | 6 | GO:0048041 | |
| GeneOntologyBiologicalProcess | microvillus organization | 1.95e-04 | 34 | 176 | 4 | GO:0032528 | |
| GeneOntologyBiologicalProcess | retina homeostasis | 2.17e-04 | 64 | 176 | 5 | GO:0001895 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.41e-04 | 144 | 176 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | response to dopamine | 2.51e-04 | 66 | 176 | 5 | GO:1903350 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | RANGAP1 DRD1 COMT NR4A2 NR4A3 NR4A1 RYR2 ITPR1 BLM PTPN2 PTPN11 PIK3CG LRP1 TAAR1 GNAL GNAS ATP2B4 | 2.52e-04 | 752 | 176 | 17 | GO:1901699 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | RANGAP1 DRD1 RIPK3 COMT NR4A2 IRAK2 NR4A3 NR4A1 PDIA3 ADCY3 KMO FABP1 ITPR1 BLM PTPN2 PTPN11 PIK3CG UCP1 LRP1 TAAR1 UGT3A2 GNAL CDK1 GNAS MAP4K4 ATP2B4 | 2.54e-04 | 1450 | 176 | 26 | GO:1901701 |
| GeneOntologyBiologicalProcess | muscle system process | FLT1 DRD1 NR4A3 NR4A1 IRAG1 LMOD2 RYR2 JARID2 PIK3CG SCN8A DMD UTRN ATP2B4 NOS1AP | 2.62e-04 | 547 | 176 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | NPC1 ABCC3 DRD1 COMT ABCC11 PTPN11 LIPC OSBPL5 LRP1 ABCC2 VPS51 | 2.64e-04 | 358 | 176 | 11 | GO:0015850 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC3 ATP6V1A ATP13A4 DRD1 ABCC11 CCDC51 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 KCNQ5 NETO1 KCNQ4 PIK3CG UCP1 SCN8A GNAS DMD ABCC2 UTRN ATP2B4 NOS1AP | 2.71e-04 | 1374 | 176 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 2.88e-04 | 68 | 176 | 5 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 2.88e-04 | 68 | 176 | 5 | GO:0071870 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNAH3 KIF21A ADCY3 LRPPRC NETO1 DNAH17 KIF14 GAPDHS SPAG16 CFAP44 ATP2B4 KIF11 CCDC40 | 3.28e-04 | 493 | 176 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 3.30e-04 | 108 | 176 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | lipid localization | NPC1 ABCC3 COMT ABCC11 FABP12 FABP1 PTPN2 PTPN11 LIPC OSBPL5 LRP1 ABCC2 VPS51 GOT2 | 3.63e-04 | 565 | 176 | 14 | GO:0010876 |
| GeneOntologyBiologicalProcess | peptidyl-cysteine S-nitrosylation | 3.80e-04 | 17 | 176 | 3 | GO:0018119 | |
| GeneOntologyBiologicalProcess | lipid transport | NPC1 ABCC3 COMT ABCC11 FABP12 FABP1 PTPN11 LIPC OSBPL5 LRP1 ABCC2 VPS51 GOT2 | 4.20e-04 | 506 | 176 | 13 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte growth factor receptor signaling pathway | 4.30e-04 | 4 | 176 | 2 | GO:1902202 | |
| GeneOntologyBiologicalProcess | 4-hydroxyproline catabolic process | 4.30e-04 | 4 | 176 | 2 | GO:0019470 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 4.30e-04 | 4 | 176 | 2 | GO:2000587 | |
| GeneOntologyBiologicalProcess | calcium ion transport | ATP13A4 DRD1 PKDREJ RYR2 ITPR1 TPCN1 CEMIP MICU1 PTPN6 PIK3CG DMD ATP2B4 NOS1AP | 4.44e-04 | 509 | 176 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | protein nitrosylation | 4.54e-04 | 18 | 176 | 3 | GO:0017014 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 4.56e-04 | 210 | 176 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 4.63e-04 | 115 | 176 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CHMP1B CEP290 CKAP5 CDK11A CLASP2 CHD3 RHO DNAH17 KIF14 RP1 CDK1 SPAG16 CFAP44 USP33 KIF11 CCDC40 | 4.63e-04 | 720 | 176 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | centrosome cycle | 5.29e-04 | 164 | 176 | 7 | GO:0007098 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 5.33e-04 | 215 | 176 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 5.33e-04 | 215 | 176 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 5.33e-04 | 44 | 176 | 4 | GO:0007212 | |
| GeneOntologyBiologicalProcess | regulation of amine metabolic process | 5.81e-04 | 45 | 176 | 4 | GO:0033238 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 6.14e-04 | 334 | 176 | 10 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 6.14e-04 | 334 | 176 | 10 | GO:0001894 | |
| GeneOntologyBiologicalProcess | phototransduction, visible light | 6.26e-04 | 20 | 176 | 3 | GO:0007603 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | VIL1 MYO5B MYCBP2 MYO9A MINK1 DPYSL5 NR4A2 NR4A3 CLASP2 CNTN6 PTPN11 EIF2B2 LRP1 MACF1 DMD MAP4K4 USP33 | 6.64e-04 | 819 | 176 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuromuscular process | 7.17e-04 | 225 | 176 | 8 | GO:0050905 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 7.26e-04 | 173 | 176 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | VIL1 MYO5B MYCBP2 MYO9A MINK1 DPYSL5 NR4A2 NR4A3 CLASP2 CNTN6 PTPN11 EIF2B2 LRP1 MACF1 DMD MAP4K4 USP33 | 7.30e-04 | 826 | 176 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 7.77e-04 | 175 | 176 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | actin filament-based process | VIL1 HIP1 MAGEL2 MYO5B MYO1H PCLO SPTAN1 MINK1 OBSCN CLASP2 LMOD2 RYR2 RHPN2 TLN1 SCN8A RHPN2P1 LRP1 NOS1AP | 8.26e-04 | 912 | 176 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | visual perception | 8.27e-04 | 230 | 176 | 8 | GO:0007601 | |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid catabolic process | 8.35e-04 | 22 | 176 | 3 | GO:0170044 | |
| GeneOntologyBiologicalProcess | sensory perception | COL11A1 PDE6A PDE6C COMT MYO9A ADGRV1 OR2T10 PKHD1L1 ADCY3 RHO CEMIP KCNQ4 SCN8A OR2D2 RP1 RP2 GNAL GNAS PPIP5K2 OR52A1 | 8.51e-04 | 1072 | 176 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 8.83e-04 | 130 | 176 | 6 | GO:1905477 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 9.00e-04 | 233 | 176 | 8 | GO:0050953 | |
| GeneOntologyBiologicalProcess | regulation of dopamine metabolic process | 9.54e-04 | 23 | 176 | 3 | GO:0042053 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | CASS4 MINK1 LAMA4 NR4A3 CLASP2 EDIL3 BLM PTPN2 PTPN6 PTPN11 PIK3CG TLN1 LRP1 KIF14 MACF1 DMD MAP4K4 UTRN | 9.94e-04 | 927 | 176 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 9.95e-04 | 89 | 176 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 1.03e-03 | 134 | 176 | 6 | GO:0030301 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | NPC1 ATP6V1A CHMP1B PPP1R3B NPEPPS KMO FABP1 ITPR1 TPCN1 LRPPRC LIPC PIK3CG AHCY LRP1 PACS2 ALDH4A1 GAPDHS ABCC2 VPS51 ATP2B4 GOT2 USP33 | 1.03e-03 | 1253 | 176 | 22 | GO:0044248 |
| GeneOntologyBiologicalProcess | presynaptic cytoskeleton organization | 1.06e-03 | 6 | 176 | 2 | GO:0099187 | |
| GeneOntologyBiologicalProcess | canalicular bile acid transport | 1.06e-03 | 6 | 176 | 2 | GO:0015722 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.06e-03 | 359 | 176 | 10 | GO:0006874 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | DRD1 RYR2 ITPR1 CEMIP PTPN6 NETO1 PIK3CG GNAS DMD UTRN ATP2B4 NOS1AP | 1.11e-03 | 493 | 176 | 12 | GO:0010959 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 1.22e-03 | 25 | 176 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 1.24e-03 | 55 | 176 | 4 | GO:0045773 | |
| GeneOntologyBiologicalProcess | sterol transport | 1.25e-03 | 139 | 176 | 6 | GO:0015918 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.29e-03 | 191 | 176 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.33e-03 | 95 | 176 | 5 | GO:0070527 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNAH3 RANGAP1 MYO5B PCLO CKAP5 CLASP2 FABP1 NETO1 DNAH17 RP1 SPAG16 CCDC40 | 5.38e-05 | 360 | 175 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | axon | RANGAP1 DRD1 COMT MYCBP2 MYO9A KIF21A PCLO SPTAN1 MINK1 CLASP2 NCDN CNTN6 KCNQ5 NETO1 SEPTIN14 EIF2B2 SCN8A LRP1 SEPTIN11 DMD | 5.95e-05 | 891 | 175 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | actin-based cell projection | VIL1 ATP6V1A UBE2Q1 MYO1H ADGRV1 PKHD1L1 LIPC DMD UTRN NOS1AP | 1.23e-04 | 278 | 175 | 10 | GO:0098858 |
| GeneOntologyCellularComponent | sarcolemma | 2.05e-04 | 190 | 175 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | Z disc | 2.87e-04 | 151 | 175 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | dendrite | RANGAP1 DRD1 COMT MYO5B ACAD9 KIF21A PCLO MINK1 DPYSL5 CKAP5 NCDN ITPR1 PTPN6 SEPTIN14 SCN8A LRP1 SEPTIN11 GNAS | 3.23e-04 | 858 | 175 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | RANGAP1 DRD1 COMT MYO5B ACAD9 KIF21A PCLO MINK1 DPYSL5 CKAP5 NCDN ITPR1 PTPN6 SEPTIN14 SCN8A LRP1 SEPTIN11 GNAS | 3.32e-04 | 860 | 175 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | HIP1 DRD1 COMT MYO5B MYO9A PCLO SPTAN1 MINK1 PSMC5 NCDN ITPR1 NETO1 EIF2B2 SCN8A LRP1 SEPTIN11 MACF1 DMD UTRN NOS1AP | 3.50e-04 | 1018 | 175 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 COL11A1 MYO9A CHMP1B KIF21A SPTAN1 OBSCN CKAP5 CLASP2 LMOD2 RYR2 LRPPRC DNAH17 SCN8A KIF14 MACF1 RP1 CDK1 DMD ATP2B4 KIF11 NOS1AP | 3.57e-04 | 1179 | 175 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 COL11A1 MYO9A CHMP1B KIF21A SPTAN1 OBSCN CKAP5 CLASP2 LMOD2 RYR2 LRPPRC DNAH17 SCN8A KIF14 MACF1 RP1 CDK1 DMD ATP2B4 KIF11 NOS1AP | 3.91e-04 | 1187 | 175 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | I band | 5.08e-04 | 166 | 175 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | glutamatergic synapse | HIP1 DRD1 COMT MYO5B MYO9A PCLO SPTAN1 DPYSL5 CLASP2 NCDN PPM1H NETO1 SCN8A LRP1 SEPTIN11 ATP2B4 NOS1AP | 5.22e-04 | 817 | 175 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | cell cortex region | 5.41e-04 | 45 | 175 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | somatodendritic compartment | RANGAP1 DRD1 COMT MYO5B ACAD9 KIF21A PCLO MINK1 DPYSL5 CKAP5 RRM1 NCDN ITPR1 PTPN6 SEPTIN14 SCN8A LRP1 SEPTIN11 GNAS DMD GOT2 USP33 | 6.18e-04 | 1228 | 175 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | membrane protein complex | ATP6V1A DRD1 MAGEL2 MLEC CHMP1B ITGAE CCDC51 PDIA3 ARCN1 RYR2 TPCN1 MICU1 PTPN6 KCNQ5 PIGH KCNQ4 PIK3CG SCN8A LRP1 CLINT1 UGT3A2 GNAL GNAS DMD UTRN | 7.30e-04 | 1498 | 175 | 25 | GO:0098796 |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.02e-03 | 6 | 175 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | cell projection membrane | DRD1 PDE6A CLASP2 ADGRV1 ADCY3 RHO TLN1 MACF1 DMD ABCC2 UTRN | 1.05e-03 | 431 | 175 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | sarcomere | 1.22e-03 | 249 | 175 | 8 | GO:0030017 | |
| MousePheno | neuron degeneration | NPC1 FLT1 PDE6A PDE6C CEP290 ADGRV1 ARCN1 RHO PTPN6 KCNQ4 SCN8A MACF1 RP1 PPIP5K2 PYCR2 | 1.45e-05 | 391 | 146 | 15 | MP:0003224 |
| Domain | Nuc_orph_rcpt | 7.54e-07 | 3 | 171 | 3 | IPR003070 | |
| Domain | G8_domain | 3.00e-06 | 4 | 171 | 3 | IPR019316 | |
| Domain | G8 | 3.00e-06 | 4 | 171 | 3 | PS51484 | |
| Domain | G8 | 3.00e-06 | 4 | 171 | 3 | SM01225 | |
| Domain | G8 | 3.00e-06 | 4 | 171 | 3 | PF10162 | |
| Domain | Pectin_lyase_fold/virulence | 4.08e-05 | 8 | 171 | 3 | IPR011050 | |
| Domain | Spectrin | 5.24e-05 | 23 | 171 | 4 | PF00435 | |
| Domain | Gprotein_alpha_S | 8.33e-05 | 2 | 171 | 2 | IPR000367 | |
| Domain | Dystrophin | 8.33e-05 | 2 | 171 | 2 | IPR016344 | |
| Domain | Tyr_Pase_non-rcpt_typ-6/11 | 8.33e-05 | 2 | 171 | 2 | IPR012152 | |
| Domain | P-loop_NTPase | ABCC3 ATP6V1A DNAH3 MYO5B MYO9A KIF21A PSMC5 ABCC11 CHD8 CHD3 UCK1 BLM MMAA SEPTIN14 SEPTIN11 KIF14 GNAL GNAS ABCC2 KIF11 | 1.01e-04 | 848 | 171 | 20 | IPR027417 |
| Domain | Spectrin_repeat | 1.35e-04 | 29 | 171 | 4 | IPR002017 | |
| Domain | SPEC | 2.00e-04 | 32 | 171 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.00e-04 | 32 | 171 | 4 | IPR018159 | |
| Domain | ARM-type_fold | PDS5B HIP1 CKAP5 CLASP2 NCDN ITPR1 PIK3CG MROH2B NCAPD2 EIF5 GCN1 | 2.99e-04 | 339 | 171 | 11 | IPR016024 |
| Domain | HEAT_REPEAT | 4.54e-04 | 70 | 171 | 5 | PS50077 | |
| Domain | ILWEQ_dom | 4.94e-04 | 4 | 171 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.94e-04 | 4 | 171 | 2 | SM00307 | |
| Domain | ILWEQ | 4.94e-04 | 4 | 171 | 2 | PD011820 | |
| Domain | CLASP_N | 4.94e-04 | 4 | 171 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 4.94e-04 | 4 | 171 | 2 | IPR024395 | |
| Domain | - | 4.94e-04 | 4 | 171 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.94e-04 | 4 | 171 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.94e-04 | 4 | 171 | 2 | PS50945 | |
| Domain | Multidrug-R_assoc | 4.94e-04 | 4 | 171 | 2 | IPR005292 | |
| Domain | Ion_trans_dom | 6.36e-04 | 114 | 171 | 6 | IPR005821 | |
| Domain | Ion_trans | 6.36e-04 | 114 | 171 | 6 | PF00520 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 8.18e-04 | 5 | 171 | 2 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 8.18e-04 | 5 | 171 | 2 | IPR003937 | |
| Domain | KCNQ_channel | 8.18e-04 | 5 | 171 | 2 | PF03520 | |
| Domain | HEAT | 9.64e-04 | 48 | 171 | 4 | PF02985 | |
| Domain | ACTININ_2 | 1.17e-03 | 23 | 171 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.17e-03 | 23 | 171 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.17e-03 | 23 | 171 | 3 | IPR001589 | |
| Domain | Pentatricopeptide_repeat | 1.17e-03 | 23 | 171 | 3 | IPR002885 | |
| Domain | RIH_assoc-dom | 1.22e-03 | 6 | 171 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.22e-03 | 6 | 171 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.22e-03 | 6 | 171 | 2 | PF08454 | |
| Domain | RIH_dom | 1.22e-03 | 6 | 171 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.22e-03 | 6 | 171 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.22e-03 | 6 | 171 | 2 | IPR015925 | |
| Domain | - | 1.22e-03 | 6 | 171 | 2 | 1.25.10.30 | |
| Domain | EF-hand_dom_typ1 | 1.22e-03 | 6 | 171 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.22e-03 | 6 | 171 | 2 | IPR015154 | |
| Domain | RYDR_ITPR | 1.22e-03 | 6 | 171 | 2 | PF01365 | |
| Domain | EF-hand_2 | 1.22e-03 | 6 | 171 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.22e-03 | 6 | 171 | 2 | PF09069 | |
| Domain | WxxW_domain | 1.22e-03 | 6 | 171 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.22e-03 | 6 | 171 | 2 | PF13330 | |
| Domain | ABC_membrane | 1.32e-03 | 24 | 171 | 3 | PF00664 | |
| Domain | EF-hand-dom_pair | 1.34e-03 | 287 | 171 | 9 | IPR011992 | |
| Domain | Kinase-like_dom | FLT1 RIPK3 HIPK4 MINK1 OBSCN IRAK2 CDK11A NEK9 PIK3CG MACF1 CDK1 DMD MAP4K4 | 1.49e-03 | 542 | 171 | 13 | IPR011009 |
| Domain | GAF | 1.70e-03 | 7 | 171 | 2 | PF01590 | |
| Domain | HEAT | 1.96e-03 | 58 | 171 | 4 | IPR000357 | |
| Domain | ABC_TM1F | 2.09e-03 | 28 | 171 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 2.09e-03 | 28 | 171 | 3 | IPR011527 | |
| Domain | AAA | 2.12e-03 | 144 | 171 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.12e-03 | 144 | 171 | 6 | IPR003593 | |
| Domain | GAF | 2.25e-03 | 8 | 171 | 2 | IPR003018 | |
| Domain | GAF | 2.25e-03 | 8 | 171 | 2 | SM00065 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPS31 PDS5B ATP6V1A RANGAP1 MLEC DSG1 ACAD9 NPEPPS PCLO SPTAN1 CKAP5 POLRMT PSMC5 CLASP2 NEK9 PDIA3 ARCN1 JARID2 LRPPRC PTPN11 FUBP1 TLN1 NCAPD2 AHCY EIF5 KIF14 CLINT1 CDK1 USP39 GNAS GALNT5 PYCR2 MAP4K4 GCN1 GOT2 KIF11 | 1.35e-15 | 1425 | 177 | 36 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B ATP6V1A RANGAP1 DSG1 MYO5B MYCBP2 NPEPPS CEP290 CKAP5 PSMC5 CHD3 EDIL3 PDIA3 NCDN ARCN1 LRPPRC FUBP1 TLN1 AHCY KIF14 MACF1 RP2 CDK1 USP39 GNAS MAP4K4 GCN1 UTRN GOT2 | 6.59e-14 | 1024 | 177 | 29 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANGAP1 UBE2Q1 KIF21A SPTAN1 CKAP5 PSMC5 CHD8 CHD3 ARCN1 BLM FUBP1 TLN1 NCAPD2 MACF1 CLINT1 CDK1 USP39 GNAS VPS51 GCN1 KIF11 | 2.83e-12 | 582 | 177 | 21 | 20467437 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B RANGAP1 COMT DSG1 MYCBP2 MYO9A NPEPPS KIF21A SPTAN1 CKAP5 POLRMT PSMC5 CHD8 RRM1 NEK9 PDIA3 ARCN1 BLM LRPPRC FUBP1 TLN1 NCAPD2 AHCY MACF1 CDK1 PYCR2 GCN1 UTRN GOT2 KIF11 | 1.13e-11 | 1353 | 177 | 30 | 29467282 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MRPS31 ATP6V1A RANGAP1 COMT MYCBP2 NPEPPS SPTAN1 CKAP5 PSMC5 CLASP2 NEK9 PDIA3 ARCN1 LRPPRC FUBP1 TLN1 NCAPD2 AHCY EIF5 SEPTIN11 MACF1 CDK1 USP39 GNAS PYCR2 GCN1 KIF11 | 3.77e-11 | 1149 | 177 | 27 | 35446349 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIPK4 MYCBP2 MYO9A SPTAN1 MINK1 DPYSL5 CKAP5 CLASP2 NEK9 PPM1H MEX3C LRPPRC KCNQ5 EIF5 KIF14 MACF1 CLINT1 GNAS PPIP5K2 MAP4K4 UTRN KIF11 NOS1AP | 1.02e-10 | 861 | 177 | 23 | 36931259 |
| Pubmed | RANGAP1 MYO5B MYCBP2 SPTAN1 MINK1 CEP290 PSMC5 CLASP2 PDIA3 PPM1H CEMIP2 ITPR1 BLM PTPN2 PTPN6 PTPN11 KIF14 CLINT1 CDK1 DMD PYCR2 GCN1 UTRN ATP2B4 NOS1AP | 1.61e-10 | 1049 | 177 | 25 | 27880917 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MRPS31 COMT MLEC MYO5B MYCBP2 ACAD9 CEP290 DPYSL5 PSMC5 CDK11A CLASP2 CCDC51 NEK9 PDIA3 PPM1H MICU1 BLM LRPPRC EIF2B2 SEPTIN11 CLINT1 RP2 PPIP5K2 SPAG16 VPS51 GCN1 MUC5AC CCDC40 | 1.68e-10 | 1321 | 177 | 28 | 27173435 |
| Pubmed | MRPS31 SCFD2 RANGAP1 MLEC MYCBP2 ACAD9 SPTAN1 MINK1 POLRMT CLASP2 ZFC3H1 DNAJB8 RRM1 PDIA3 NCDN CEMIP2 ITPR1 MICU1 BLM PTPN2 LRPPRC TLN1 MACF1 GNAS PYCR2 MAP4K4 ATP2B4 USP33 NOS1AP | 5.23e-10 | 1487 | 177 | 29 | 33957083 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MRPS31 RANGAP1 DSG1 MYCBP2 ACAD9 NPEPPS PSMC5 CLASP2 ARCN1 MICU1 PTPN2 LRPPRC PIK3CG LRP1 CLINT1 GNAL CDK1 USP39 MAP4K4 GCN1 UTRN USP33 KIF11 | 2.01e-09 | 1005 | 177 | 23 | 19615732 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATP6V1A MYCBP2 MYO9A PPFIBP2 NPEPPS MINK1 DPYSL5 OBSCN CLASP2 CHD3 ADGRV1 NEK9 ADCY3 NCDN PPM1H MICU1 LRPPRC KCNQ5 NETO1 FUBP1 OSBPL5 LRP1 SEPTIN11 MACF1 GNAS TATDN1 PCDH1 UTRN | 2.41e-09 | 1489 | 177 | 28 | 28611215 |
| Pubmed | MRPS31 ATP6V1A RANGAP1 MLEC DSG1 MYCBP2 PCLO SPTAN1 MINK1 CKAP5 ARCN1 RYR2 ITPR1 MICU1 PTPN2 LRPPRC KCNQ5 SEPTIN11 MACF1 PYCR2 VPS51 MAP4K4 GCN1 NOS1AP | 4.34e-09 | 1139 | 177 | 24 | 36417873 | |
| Pubmed | RANGAP1 MLEC MYO9A MINK1 CKAP5 PSMC5 RRM1 ARCN1 LRPPRC PTPN11 TLN1 NCAPD2 AHCY EIF5 MACF1 CLINT1 CDK1 MAP4K4 GCN1 | 4.48e-09 | 708 | 177 | 19 | 39231216 | |
| Pubmed | ATP6V1A MYO5B MYO9A NPEPPS PCLO SPTAN1 MINK1 DPYSL5 CKAP5 CLASP2 CHD3 PDIA3 NCDN ARCN1 LRPPRC TLN1 SEPTIN11 PACS2 MACF1 DMD PYCR2 VPS51 PCDH1 UTRN HSDL1 ATP2B4 GOT2 | 4.49e-09 | 1431 | 177 | 27 | 37142655 | |
| Pubmed | ATP6V1A RANGAP1 SPTAN1 CKAP5 PSMC5 CLASP2 RRM1 NEK9 ARCN1 LRPPRC TLN1 NCAPD2 CLINT1 CDK1 USP39 PYCR2 GCN1 KIF11 | 5.42e-09 | 638 | 177 | 18 | 33239621 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B FLT1 ACAD9 NPEPPS DPYSL5 OBSCN POLRMT CDK11A CLASP2 KMO BLM NCAPD2 RP1 USP39 GALNT5 MAP4K4 | 6.38e-09 | 497 | 177 | 16 | 36774506 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MRPS31 VIL1 UBQLNL DNAH3 RANGAP1 KIF21A PCLO CEP290 OBSCN CKAP5 ITGAE ARCN1 TLN1 SCN8A RXFP1 CDK1 USP39 CFAP44 UTRN | 8.36e-09 | 736 | 177 | 19 | 29676528 |
| Pubmed | RANGAP1 HIP1 CKAP5 PSMC5 NEK9 ARCN1 TLN1 NCAPD2 EIF5 CLINT1 CDK1 GCN1 UTRN USP33 KIF11 | 1.19e-08 | 449 | 177 | 15 | 31732153 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1A DNAH3 RANGAP1 KIF21A SPTAN1 CKAP5 PSMC5 CHD3 RRM1 ARCN1 FUBP1 TLN1 NCAPD2 EIF5 SEPTIN11 MACF1 CDK1 MAP4K4 UTRN ATP2B4 | 1.46e-08 | 847 | 177 | 20 | 35235311 |
| Pubmed | MRPS31 SCFD2 ATP6V1A RANGAP1 HIP1 MLEC ACAD9 NPEPPS SPTAN1 POLRMT PSMC5 RRM1 PDIA3 ARCN1 ITPR1 LRPPRC TLN1 EIF2B2 NCAPD2 KIF14 CLINT1 CDK1 USP39 GNAS PYCR2 GCN1 | 2.18e-08 | 1440 | 177 | 26 | 30833792 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP6V1A MYO5B NPEPPS KIF21A PCLO SPTAN1 MINK1 PSMC5 ITPR1 AHCY EIF5 SEPTIN11 GNAL GAPDHS GNAS MAP4K4 GOT2 | 2.28e-08 | 621 | 177 | 17 | 22794259 |
| Pubmed | ATP6V1A RANGAP1 HIP1 COMT MLEC ACAD9 NPEPPS PSMC5 RRM1 PDIA3 ARCN1 LRPPRC PTPN11 TLN1 AHCY EIF5 CDK1 PYCR2 GCN1 GOT2 | 2.65e-08 | 878 | 177 | 20 | 37223481 | |
| Pubmed | NPC1 COMT MLEC MYCBP2 CEP290 CKAP5 PSMC5 CLASP2 ADCY3 NCDN ARCN1 ITPR1 LRPPRC PIK3CG NCAPD2 OSBPL5 KIF14 CLINT1 CDK1 GNAS GCN1 ATP2B4 KIF11 | 3.25e-08 | 1168 | 177 | 23 | 19946888 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NPC1 RANGAP1 HIP1 DSG1 NPEPPS KIF21A CKAP5 PSMC5 RRM1 PDIA3 ARCN1 PTPN2 LRPPRC PTPN11 TLN1 NCAPD2 AHCY EIF5 LRP1 SEPTIN11 GNAS GCN1 UTRN GOT2 KIF11 | 3.27e-08 | 1367 | 177 | 25 | 32687490 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP6V1A MLEC MYCBP2 NPEPPS PCLO SPTAN1 CHD8 PDIA3 ARCN1 LRPPRC TLN1 SCN8A AHCY PACS2 MACF1 GNAS GCN1 UTRN GOT2 | 3.60e-08 | 807 | 177 | 19 | 30575818 |
| Pubmed | PDS5B RANGAP1 MYCBP2 NPEPPS SPTAN1 CKAP5 POLRMT PSMC5 CHD8 BLM LRPPRC TLN1 NCAPD2 KIF14 MACF1 GCN1 UTRN | 4.72e-08 | 653 | 177 | 17 | 22586326 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | NPC1 VIL1 ATP6V1A COMT MYO5B CHMP1B NPEPPS MINK1 PSMC5 ABCC11 ADGRV1 CEMIP2 FABP1 SIAE PTPN6 TLN1 AHCY RP2 CDK1 SDCBP2 UTRN | 6.04e-08 | 1016 | 177 | 21 | 19056867 |
| Pubmed | ATP6V1A COL11A1 COMT MLEC NPEPPS SPTAN1 OBSCN LAMA4 EDIL3 PDIA3 ARCN1 LRPPRC LRP1 SEPTIN11 ALDH4A1 RP2 PYCR2 UTRN GOT2 | 9.52e-08 | 859 | 177 | 19 | 31536960 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | MRPS31 SPTAN1 CDK11A PDIA3 ARCN1 LRPPRC PTPN11 FUBP1 TLN1 EIF5 CLINT1 CDK1 USP39 PYCR2 GCN1 GOT2 | 1.01e-07 | 607 | 177 | 16 | 39147351 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SCFD2 PDS5B RANGAP1 CKAP5 CLASP2 EDIL3 NEK9 PDIA3 NCDN ARCN1 ITPR1 BLM TLN1 AHCY KIF14 CLINT1 GNAL CDK1 USP39 GNAS GCN1 GOT2 | 1.18e-07 | 1155 | 177 | 22 | 20360068 |
| Pubmed | RANGAP1 MYCBP2 NPEPPS KIF21A SPTAN1 MINK1 CKAP5 CHD8 CLASP2 NEK9 NCDN PPM1H LRPPRC NETO1 LRP1 SEPTIN11 MACF1 MAP4K4 ATP2B4 KIF11 | 1.18e-07 | 963 | 177 | 20 | 28671696 | |
| Pubmed | 1.26e-07 | 46 | 177 | 6 | 34265304 | ||
| Pubmed | NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. | 1.30e-07 | 3 | 177 | 3 | 22996661 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 10523643 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 36482877 | ||
| Pubmed | The NR4A orphan nuclear receptors: mediators in metabolism and diseases. | 1.30e-07 | 3 | 177 | 3 | 25089663 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 15910281 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 27159982 | ||
| Pubmed | The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. | 1.30e-07 | 3 | 177 | 3 | 22143616 | |
| Pubmed | The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. | 1.30e-07 | 3 | 177 | 3 | 25605333 | |
| Pubmed | Minireview: What is Known about SUMOylation Among NR4A Family Members? | 1.30e-07 | 3 | 177 | 3 | 34437889 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 24753204 | ||
| Pubmed | Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. | 1.30e-07 | 3 | 177 | 3 | 21621845 | |
| Pubmed | Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. | 1.30e-07 | 3 | 177 | 3 | 18945812 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 15964844 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 20659174 | ||
| Pubmed | NR4A transcription factors limit CAR T cell function in solid tumours. | 1.30e-07 | 3 | 177 | 3 | 30814732 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 19465082 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 25899083 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 16873729 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 28808448 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 25199433 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 24005216 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 25917081 | ||
| Pubmed | FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts. | 1.30e-07 | 3 | 177 | 3 | 18809462 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MLEC ACAD9 NPEPPS DPYSL5 CKAP5 POLRMT PSMC5 PDIA3 PTPN2 LRPPRC PTPN6 PTPN11 LRP1 CDK1 GNAS DMD PYCR2 GCN1 UTRN KIF11 | 1.42e-07 | 974 | 177 | 20 | 28675297 |
| Pubmed | 1.44e-07 | 47 | 177 | 6 | 11208732 | ||
| Pubmed | DSG1 NPEPPS SPTAN1 PSMC5 RRM1 PDIA3 LRPPRC FUBP1 TLN1 AHCY CDK1 GCN1 GOT2 | 1.45e-07 | 397 | 177 | 13 | 21319273 | |
| Pubmed | NPC1 ATP6V1A MLEC MYCBP2 ACAD9 KIF21A SPTAN1 POLRMT PSMC5 RRM1 PDIA3 LRPPRC TAMM41 FUBP1 AHCY EIF5 SEPTIN11 MACF1 FAM3C CDK1 GNAS GOT2 KIF11 | 2.11e-07 | 1297 | 177 | 23 | 33545068 | |
| Pubmed | SCFD2 RANGAP1 SPTAN1 CKAP5 ARCN1 CEMIP2 ITPR1 PTPN2 PTPN11 TLN1 AHCY EIF5 CLINT1 GCN1 USP33 | 2.51e-07 | 568 | 177 | 15 | 37774976 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRPS31 ATP6V1A RANGAP1 DSG1 KIF21A SPTAN1 CKAP5 CLASP2 RRM1 CCDC51 NEK9 PDIA3 NCDN ARCN1 LRPPRC PTPN11 TLN1 NCAPD2 AHCY MACF1 CDK1 USP39 GCN1 KIF11 | 2.51e-07 | 1415 | 177 | 24 | 28515276 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | SPTAN1 CKAP5 PSMC5 ITGAE PTPN11 SEPTIN14 NCAPD2 GNAL GNAS GCN1 | 3.36e-07 | 231 | 177 | 10 | 36597993 |
| Pubmed | MRPS31 VIL1 PDS5B RANGAP1 GGNBP2 PDE6A MYO5B KIF21A PCLO SPTAN1 CHD3 ZFC3H1 PDIA3 RYR2 ADAMTS12 LRPPRC FUBP1 NCAPD2 MACF1 DMD ABCC2 PPIP5K2 PYCR2 KIF11 | 3.53e-07 | 1442 | 177 | 24 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1A RANGAP1 NPEPPS KIF21A SPTAN1 PSMC5 RRM1 NEK9 PDIA3 NCDN ARCN1 PTPN11 FUBP1 TLN1 EIF2B2 NCAPD2 AHCY EIF5 SEPTIN11 MACF1 CLINT1 CDK1 TATDN1 GCN1 | 4.15e-07 | 1455 | 177 | 24 | 22863883 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MRPS31 CCDC9B DSG1 MYO5B SPTAN1 CKAP5 POLRMT ZFC3H1 EDIL3 ARCN1 MICU1 PTPN2 LRPPRC AHCY EIF5 KIF14 CLINT1 CDK1 USP39 GAPDHS GNAS KIF11 | 4.94e-07 | 1257 | 177 | 22 | 36526897 |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 24034253 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 31152140 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 20421975 | ||
| Pubmed | Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. | 5.16e-07 | 4 | 177 | 3 | 15910753 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 14525795 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 22789442 | ||
| Pubmed | Trained immunity induced by high-salt diet impedes stroke recovery. | 5.16e-07 | 4 | 177 | 3 | 37965920 | |
| Pubmed | Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia. | 5.16e-07 | 4 | 177 | 3 | 37961948 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 30089271 | ||
| Pubmed | Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. | 5.16e-07 | 4 | 177 | 3 | 23334790 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 33665581 | ||
| Pubmed | MRPS31 ATP6V1A RANGAP1 MLEC DSG1 PSMC5 CDK11A PDIA3 ARCN1 BLM LRPPRC FUBP1 TLN1 EIF2B2 AHCY CDK1 PYCR2 | 6.37e-07 | 786 | 177 | 17 | 29128334 | |
| Pubmed | NPC1 ATP6V1A COMT NPEPPS CKAP5 PSMC5 RRM1 CEMIP2 SIAE LRPPRC AHCY LRP1 CDK1 GCN1 KIF11 | 6.56e-07 | 613 | 177 | 15 | 22268729 | |
| Pubmed | MRPS31 DSG1 MYCBP2 CKAP5 POLRMT PSMC5 PDIA3 ARCN1 LRPPRC FUBP1 NCAPD2 SEPTIN11 CDK1 USP39 DMD GCN1 KIF11 | 9.45e-07 | 809 | 177 | 17 | 32129710 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDS5B ABCC3 COMT PPFIBP2 EDIL3 PDIA3 MACF1 GALNT5 ABCC2 PYCR2 VPS51 MAP4K4 UTRN ATP2B4 GOT2 KIF11 | 9.55e-07 | 719 | 177 | 16 | 35337019 |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 9.65e-07 | 102 | 177 | 7 | 20508983 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.13e-06 | 264 | 177 | 10 | 32814769 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ATP6V1A RANGAP1 KIF21A SPTAN1 PSMC5 PGM2L1 CLASP2 TLN1 AHCY ALDH4A1 CLINT1 GNAS MAP4K4 PCDH1 | 1.17e-06 | 558 | 177 | 14 | 35063084 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ATP6V1A COL11A1 CCDC9B MYO9A PPFIBP2 NPEPPS CKAP5 PSMC5 CHD3 PDIA3 MEX3C AHCY KIF14 GAPDHS ABCC2 GCN1 | 1.21e-06 | 732 | 177 | 16 | 34732716 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANGAP1 SPTAN1 CKAP5 PSMC5 CHD8 CHD3 RRM1 TLN1 NCAPD2 GCN1 KIF11 | 1.21e-06 | 332 | 177 | 11 | 32786267 |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 20705734 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 15155786 | ||
| Pubmed | Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells. | 1.29e-06 | 5 | 177 | 3 | 26304965 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 2563260 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 8961274 | ||
| Pubmed | GGNBP2 MINK1 POLRMT CHD8 CHD3 NCDN CEMIP2 ITPR1 CEMIP RHPN2 GAPDHS PPIP5K2 MAP4K4 HSDL1 USP33 | 1.36e-06 | 650 | 177 | 15 | 38777146 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATP6V1A RANGAP1 DSG1 CKAP5 PSMC5 CHD3 NEK9 PDIA3 ARCN1 PTPN11 TLN1 AHCY EIF5 MACF1 CLINT1 GCN1 UTRN KIF11 | 1.53e-06 | 934 | 177 | 18 | 33916271 |
| Pubmed | PDS5B ATP6V1A RANGAP1 HIP1 SPTAN1 PSMC5 CDK11A KIF14 MACF1 CLINT1 RP2 CDK1 USP39 GNAS NOS1AP | 1.64e-06 | 660 | 177 | 15 | 32780723 | |
| Pubmed | 1.81e-06 | 216 | 177 | 9 | 31519766 | ||
| Pubmed | 2.04e-06 | 163 | 177 | 8 | 16512683 | ||
| Pubmed | 2.08e-06 | 41 | 177 | 5 | 21052544 | ||
| Pubmed | ATP6V1A COMT DSG1 MYCBP2 CEMIP2 LRPPRC AHCY GNAS PPIP5K2 ATP2B4 | 2.47e-06 | 288 | 177 | 10 | 38496616 | |
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 17194762 | ||
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 25809189 | ||
| Pubmed | 2.60e-06 | 76 | 177 | 6 | 27542412 | ||
| Interaction | BIRC3 interactions | MRPS31 PDS5B ATP6V1A RANGAP1 RIPK3 MLEC DSG1 ACAD9 NPEPPS SPTAN1 CKAP5 POLRMT PSMC5 NEK9 PDIA3 ARCN1 JARID2 LRPPRC FUBP1 TLN1 NCAPD2 AHCY EIF5 PACS2 CLINT1 CDK1 GNAS GALNT5 PYCR2 GCN1 GOT2 KIF11 | 1.39e-07 | 1334 | 175 | 32 | int:BIRC3 |
| Interaction | CCDC8 interactions | DSG1 MYO5B MYCBP2 NPEPPS CEP290 CKAP5 CHD3 EDIL3 PDIA3 NCDN ARCN1 LRPPRC MACF1 RP2 CDK1 USP39 GNAS GCN1 UTRN | 4.57e-06 | 656 | 175 | 19 | int:CCDC8 |
| Interaction | GBF1 interactions | RANGAP1 CKAP5 PSMC5 CHD8 PTPN6 PTPN11 MROH2B TLN1 EIF5 SEPTIN11 KIF14 CLINT1 CDK1 GCN1 KIF11 | 7.67e-06 | 442 | 175 | 15 | int:GBF1 |
| Interaction | MAGEL2 interactions | 1.47e-05 | 61 | 175 | 6 | int:MAGEL2 | |
| Interaction | FBXO22 interactions | PDS5B FLT1 ACAD9 NPEPPS DPYSL5 OBSCN POLRMT CDK11A CLASP2 KMO BLM NCAPD2 RP1 USP39 GALNT5 MAP4K4 | 2.04e-05 | 540 | 175 | 16 | int:FBXO22 |
| Interaction | KCNA3 interactions | RANGAP1 MLEC MYO9A MINK1 CKAP5 PSMC5 RRM1 ARCN1 LRPPRC PTPN11 TLN1 NCAPD2 AHCY EIF5 MACF1 CLINT1 RP1 CDK1 MAP4K4 GCN1 KIF11 | 2.30e-05 | 871 | 175 | 21 | int:KCNA3 |
| Interaction | BAP1 interactions | MRPS31 ATP6V1A RANGAP1 COMT MYCBP2 NPEPPS SPTAN1 CKAP5 PSMC5 CLASP2 NEK9 PDIA3 ARCN1 LRPPRC FUBP1 TLN1 NCAPD2 AHCY EIF5 SEPTIN11 MACF1 CDK1 USP39 GNAS PYCR2 GCN1 KIF11 | 2.57e-05 | 1314 | 175 | 27 | int:BAP1 |
| Interaction | H2BC12 interactions | PDS5B MYO1H PCLO CKAP5 CLASP2 CHD3 RRM1 PDIA3 ADAMTS12 EIF5 KIF14 FAM3C | 2.59e-05 | 322 | 175 | 12 | int:H2BC12 |
| Interaction | SIRT7 interactions | PDS5B RANGAP1 MYCBP2 NPEPPS SPTAN1 CKAP5 POLRMT PSMC5 CHD8 BLM LRPPRC TLN1 NCAPD2 KIF14 MACF1 CDK1 USP39 GCN1 UTRN | 2.67e-05 | 744 | 175 | 19 | int:SIRT7 |
| Interaction | YWHAH interactions | MYCBP2 MYO9A PPFIBP2 SPTAN1 MINK1 CEP290 DPYSL5 CKAP5 CLASP2 PPM1H MEX3C KCNQ5 RHPN2 OSBPL5 EIF5 KIF14 PACS2 MACF1 CLINT1 PPIP5K2 MAP4K4 UTRN KIF11 NOS1AP | 3.03e-05 | 1102 | 175 | 24 | int:YWHAH |
| Interaction | LYPD3 interactions | 3.27e-05 | 141 | 175 | 8 | int:LYPD3 | |
| Interaction | RNF123 interactions | MRPS31 VIL1 UBQLNL DNAH3 RANGAP1 KIF21A PCLO CEP290 OBSCN CKAP5 ITGAE ARCN1 TLN1 SCN8A RXFP1 CDK1 USP39 CFAP44 UTRN D2HGDH | 3.33e-05 | 824 | 175 | 20 | int:RNF123 |
| Interaction | CALM1 interactions | MYO5B MYCBP2 CEP290 OBSCN POLRMT PDIA3 PTH2R RYR2 ITPR1 LRPPRC KCNQ5 HINT3 KIF14 CLINT1 GNAS UTRN ATP2B4 | 3.38e-05 | 626 | 175 | 17 | int:CALM1 |
| Interaction | LAIR1 interactions | 3.49e-05 | 8 | 175 | 3 | int:LAIR1 | |
| Interaction | PTPRN2 interactions | 4.14e-05 | 73 | 175 | 6 | int:PTPRN2 | |
| Interaction | HNRNPCL3 interactions | 4.28e-05 | 23 | 175 | 4 | int:HNRNPCL3 | |
| Interaction | CDC5L interactions | RANGAP1 KIF21A SPTAN1 CKAP5 PSMC5 CHD8 CHD3 ARCN1 PTPN6 FUBP1 TLN1 NCAPD2 KIF14 MACF1 CLINT1 USP39 GNAS VPS51 GCN1 KIF11 | 5.56e-05 | 855 | 175 | 20 | int:CDC5L |
| Interaction | STIP1 interactions | ATP6V1A RANGAP1 RIPK3 SPTAN1 CKAP5 PSMC5 CLASP2 DNAJB8 RRM1 NEK9 ARCN1 LRPPRC PTPN11 KCNQ4 TLN1 NCAPD2 CLINT1 CDK1 USP39 PYCR2 GCN1 KIF11 | 6.30e-05 | 1006 | 175 | 22 | int:STIP1 |
| Interaction | HRAS interactions | ABCC3 PPFIBP2 ACAD9 SPTAN1 MINK1 IRAK2 OR2T10 CEMIP2 RHPN2 PIK3CG FUBP1 HINT3 SEPTIN11 RP2 VPS51 MAP4K4 PCDH1 ATP2B4 | 6.31e-05 | 725 | 175 | 18 | int:HRAS |
| Interaction | ATOH1 interactions | 6.95e-05 | 80 | 175 | 6 | int:ATOH1 | |
| Interaction | KCTD13 interactions | ATP6V1A MYO5B MYO9A NPEPPS PCLO SPTAN1 MINK1 DPYSL5 CKAP5 CLASP2 CHD3 PDIA3 NCDN ARCN1 LRPPRC TLN1 SEPTIN11 PACS2 MACF1 DMD PYCR2 VPS51 PCDH1 UTRN HSDL1 ATP2B4 GOT2 | 7.09e-05 | 1394 | 175 | 27 | int:KCTD13 |
| Interaction | HTT interactions | ATP6V1A RANGAP1 HIP1 MYO5B NPEPPS KIF21A PCLO SPTAN1 MINK1 PSMC5 CHD3 ZFC3H1 ITPR1 AHCY EIF5 SEPTIN11 GNAL GAPDHS GNAS MAP4K4 GOT2 | 7.93e-05 | 949 | 175 | 21 | int:HTT |
| Interaction | WWTR1 interactions | RANGAP1 MYCBP2 SPTAN1 CHD8 NEK9 ARCN1 PTPN11 TLN1 NCAPD2 CLINT1 USP39 MAP4K4 GCN1 | 8.47e-05 | 422 | 175 | 13 | int:WWTR1 |
| Interaction | PAFAH1B1 interactions | 8.94e-05 | 258 | 175 | 10 | int:PAFAH1B1 | |
| Interaction | SNW1 interactions | RANGAP1 UBE2Q1 KIF21A SPTAN1 CKAP5 PSMC5 CHD8 CHD3 ARCN1 BLM FUBP1 TLN1 NCAPD2 AHCY KIF14 CDK1 GCN1 KIF11 | 9.22e-05 | 747 | 175 | 18 | int:SNW1 |
| Interaction | LILRB4 interactions | 9.56e-05 | 28 | 175 | 4 | int:LILRB4 | |
| Interaction | SEC14L2 interactions | 1.10e-04 | 29 | 175 | 4 | int:SEC14L2 | |
| Interaction | SERBP1 interactions | ATP6V1A RANGAP1 HIP1 MAGEL2 COMT MLEC ACAD9 NPEPPS PCLO SPTAN1 CKAP5 PSMC5 CHD3 RRM1 PDIA3 ARCN1 LRPPRC PTPN11 FUBP1 TLN1 AHCY EIF5 KIF14 CDK1 PYCR2 GCN1 GOT2 | 1.11e-04 | 1432 | 175 | 27 | int:SERBP1 |
| Interaction | ASAH1 interactions | 1.26e-04 | 89 | 175 | 6 | int:ASAH1 | |
| Interaction | CIT interactions | PDS5B RANGAP1 HIP1 NPEPPS MYO1H PCLO SPTAN1 CKAP5 PSMC5 CDK11A CHD8 CLASP2 CHD3 ADGRV1 RRM1 LRPPRC PIK3CG MROH2B KIF14 MACF1 CDK1 USP39 GAPDHS GNAS GCN1 KIF11 CCDC40 | 1.36e-04 | 1450 | 175 | 27 | int:CIT |
| Interaction | SLX4 interactions | PDS5B ATP6V1A RANGAP1 DSG1 PSMC5 CDK11A CHD8 ZFC3H1 POLR3F BLM PTPN11 AHCY CLINT1 PYCR2 GCN1 | 1.46e-04 | 572 | 175 | 15 | int:SLX4 |
| Interaction | SENP1 interactions | 1.49e-04 | 131 | 175 | 7 | int:SENP1 | |
| Interaction | PIK3CG interactions | 1.60e-04 | 59 | 175 | 5 | int:PIK3CG | |
| Interaction | MED4 interactions | MYCBP2 SPTAN1 CEP290 CKAP5 PSMC5 CDK11A NEK9 TLN1 KIF14 CLINT1 SDCBP2 UTRN KIF11 | 1.60e-04 | 450 | 175 | 13 | int:MED4 |
| Interaction | COX4I1 interactions | MRPS31 ATP6V1A UBE2Q1 ACAD9 POLRMT PDIA3 MICU1 LRPPRC PIGH KIF14 ALDH4A1 PYCR2 GOT2 | 1.67e-04 | 452 | 175 | 13 | int:COX4I1 |
| Interaction | AGR2 interactions | ATP6V1A MLEC MYCBP2 NPEPPS PCLO SPTAN1 CHD8 PDIA3 ARCN1 LRPPRC TLN1 SCN8A AHCY PACS2 MACF1 GNAS GCN1 MUC5AC UTRN GOT2 | 1.83e-04 | 934 | 175 | 20 | int:AGR2 |
| Interaction | PTPN20 interactions | 2.18e-04 | 14 | 175 | 3 | int:PTPN20 | |
| Interaction | IQSEC3 interactions | 2.18e-04 | 14 | 175 | 3 | int:IQSEC3 | |
| Interaction | MPIG6B interactions | 2.24e-04 | 3 | 175 | 2 | int:MPIG6B | |
| Interaction | MCAM interactions | NPC1 MINK1 LAMA4 ADCY3 CEMIP2 SEPTIN11 RP2 GNAS DMD MAP4K4 PCDH1 UTRN ATP2B4 | 2.35e-04 | 468 | 175 | 13 | int:MCAM |
| Interaction | SOX2 interactions | MRPS31 ATP6V1A RANGAP1 COL11A1 CCDC9B MYO9A PPFIBP2 NPEPPS SPTAN1 CKAP5 PSMC5 CDK11A CHD8 CHD3 PDIA3 MEX3C FUBP1 NCAPD2 AHCY KIF14 MACF1 CLINT1 CDK1 GAPDHS ABCC2 GCN1 | 2.45e-04 | 1422 | 175 | 26 | int:SOX2 |
| GeneFamily | ATP binding cassette subfamily C | 6.16e-05 | 13 | 111 | 3 | 807 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.72e-04 | 18 | 111 | 3 | 812 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | KLHL6 MYCBP2 PGM2L1 CHD3 TBC1D8B NEK9 MACF1 ALDH4A1 MAP4K4 UTRN | 5.31e-07 | 184 | 177 | 10 | M9005 |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 2.13e-06 | 167 | 177 | 9 | M365 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.95e-06 | 180 | 177 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B MYCBP2 NPEPPS CKAP5 CLASP2 ITPR1 CEMIP BLM JARID2 PTPN2 LRPPRC FUBP1 KIF14 MACF1 CLINT1 DMD PPIP5K2 ATP2B4 KIF11 | 5.84e-06 | 856 | 177 | 19 | M4500 |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP | 1.26e-05 | 158 | 177 | 8 | M8888 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.65e-05 | 164 | 177 | 8 | M13108 | |
| Coexpression | FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN | 1.99e-05 | 49 | 177 | 5 | M11250 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | PDS5B DSG1 MYCBP2 MRPL33 CLASP2 ARCN1 KMO PTPN11 EIF5 LRP1 FAM3C CLINT1 RP2 GAPDHS PPIP5K2 USP33 | 2.53e-05 | 705 | 177 | 16 | M1410 |
| Coexpression | JIANG_MELANOMA_TRM7_CD8 | 3.39e-05 | 90 | 177 | 6 | M48971 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 3.90e-05 | 185 | 177 | 8 | M19511 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 3.90e-05 | 185 | 177 | 8 | M2965 | |
| Coexpression | CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL | 4.59e-05 | 139 | 177 | 7 | M39322 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 5.38e-05 | 250 | 177 | 9 | M11318 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 5.87e-05 | 196 | 177 | 8 | M9243 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 6.53e-05 | 199 | 177 | 8 | M9236 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 6.77e-05 | 200 | 177 | 8 | M7773 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP | 6.77e-05 | 200 | 177 | 8 | M9281 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 NPEPPS CKAP5 CLASP2 CEMIP BLM JARID2 PTPN2 LRPPRC FUBP1 KIF14 KIF11 | 8.30e-05 | 466 | 177 | 12 | M13522 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | GGNBP2 COMT SPTAN1 MINK1 NR4A2 CHD3 ADCY3 MEX3C PTPN2 LRP1 KIF14 MACF1 CLINT1 CDK1 GNAS PPIP5K2 | 9.69e-05 | 790 | 177 | 16 | M12490 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.15e-04 | 276 | 177 | 9 | M41128 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.20e-04 | 162 | 177 | 7 | M45037 | |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | MYCBP2 UBD KIF21A PCLO NR4A2 IRAK2 NR4A3 PKHD1L1 SIAE GVINP1 NOS1AP | 1.23e-04 | 413 | 177 | 11 | M2494 |
| Coexpression | NEWMAN_ERCC6_TARGETS_DN | 1.37e-04 | 39 | 177 | 4 | M6239 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | CEP290 CKAP5 RRM1 BLM FUBP1 NCAPD2 KIF14 CLINT1 CDK1 KIF11 DNTT | 1.61e-04 | 426 | 177 | 11 | M9516 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.62e-04 | 289 | 177 | 9 | M2196 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | KLHL6 FLT1 MAGEL2 LAMA4 IRAK2 NR4A3 CLASP2 COLEC10 NR4A1 IRAG1 EDIL3 RYR2 CNTN6 CEMIP KCNQ5 TAMM41 NETO1 NCAPD2 SPIN2A GALNT5 GCN1 | 5.81e-06 | 837 | 175 | 21 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 7.12e-06 | 86 | 175 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | KLHL6 FLT1 MAGEL2 LAMA4 NR4A3 CLASP2 COLEC10 IRAG1 EDIL3 RYR2 CNTN6 CEMIP KCNQ5 GALNT5 | 1.07e-05 | 420 | 175 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | PDS5B FLT1 PPP1R3B LAMA4 IRAK2 NR4A3 CLASP2 COLEC10 IRAG1 RRM1 EDIL3 RYR2 CEMIP PTPN11 KCNQ5 NETO1 RP2 GCN1 UTRN KIF11 | 1.27e-05 | 811 | 175 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 7.24e-05 | 166 | 175 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_200 | 8.20e-05 | 169 | 175 | 8 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | ABCC3 COL11A1 MAGEL2 MYO5B CHMP1B PPP1R3B PPFIBP2 KIF21A CEP290 IRAK2 NR4A3 PGM2L1 CLASP2 NR4A1 EDIL3 FABP1 RHPN2 SDCBP2 | 8.26e-05 | 780 | 175 | 18 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | CASS4 RRM1 KMO ITPR1 BLM NCAPD2 KIF14 CDK1 ATP2B4 KIF11 NOS1AP DNTT | 9.47e-05 | 388 | 175 | 12 | GSM538352_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | CASS4 CEP290 RRM1 KMO BLM NCAPD2 KIF14 CDK1 ATP2B4 KIF11 NOS1AP DNTT | 1.23e-04 | 399 | 175 | 12 | GSM538345_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_100 | 1.87e-04 | 14 | 175 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | NR4A3 CHD3 NR4A1 RRM1 ITGAE BLM NCAPD2 KIF14 CDK1 UTRN KIF11 DNTT | 2.07e-04 | 422 | 175 | 12 | GSM476658_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | PDS5B NR4A2 NR4A3 COLEC10 IRAG1 EDIL3 RYR2 CNTN6 CEMIP KCNQ5 NETO1 RP2 | 2.07e-04 | 422 | 175 | 12 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-07 | 200 | 176 | 9 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-07 | 169 | 176 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-07 | 176 | 176 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 177 | 176 | 8 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-07 | 179 | 176 | 8 | 5297f7459b40ca780a1983fecc1bb9c035c7677e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-07 | 183 | 176 | 8 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-07 | 186 | 176 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-07 | 187 | 176 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-07 | 187 | 176 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.55e-07 | 188 | 176 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.26e-07 | 190 | 176 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.26e-07 | 190 | 176 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.00e-06 | 192 | 176 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.04e-06 | 193 | 176 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.04e-06 | 193 | 176 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 194 | 176 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 195 | 176 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-06 | 195 | 176 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.13e-06 | 135 | 176 | 7 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-06 | 197 | 176 | 8 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 197 | 176 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 1.22e-06 | 197 | 176 | 8 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.22e-06 | 197 | 176 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 198 | 176 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-06 | 198 | 176 | 8 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.50e-06 | 152 | 176 | 7 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-06 | 156 | 176 | 7 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.81e-06 | 162 | 176 | 7 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 163 | 176 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 168 | 176 | 7 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-06 | 170 | 176 | 7 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.43e-06 | 171 | 176 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 175 | 176 | 7 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 175 | 176 | 7 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-06 | 176 | 176 | 7 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 6.81e-06 | 177 | 176 | 7 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.33e-06 | 179 | 176 | 7 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 179 | 176 | 7 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.17e-06 | 182 | 176 | 7 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.47e-06 | 183 | 176 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.47e-06 | 183 | 176 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 184 | 176 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 184 | 176 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 184 | 176 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 184 | 176 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 185 | 176 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 185 | 176 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 185 | 176 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 186 | 176 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-06 | 186 | 176 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 9.75e-06 | 187 | 176 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 187 | 176 | 7 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 187 | 176 | 7 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 187 | 176 | 7 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.75e-06 | 187 | 176 | 7 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 188 | 176 | 7 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 188 | 176 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 188 | 176 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 188 | 176 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 188 | 176 | 7 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 189 | 176 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.04e-05 | 189 | 176 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.04e-05 | 189 | 176 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 190 | 176 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 190 | 176 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 190 | 176 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 190 | 176 | 7 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 191 | 176 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-05 | 191 | 176 | 7 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-05 | 191 | 176 | 7 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 192 | 176 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 192 | 176 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 176 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 194 | 176 | 7 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 195 | 176 | 7 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-05 | 195 | 176 | 7 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 196 | 176 | 7 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 196 | 176 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.32e-05 | 196 | 176 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 197 | 176 | 7 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 197 | 176 | 7 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 197 | 176 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 197 | 176 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 197 | 176 | 7 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 198 | 176 | 7 | a11ac83dbd69d1c068971266d7c7343d114a6294 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-05 | 198 | 176 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-05 | 198 | 176 | 7 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.46e-05 | 199 | 176 | 7 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| Drug | dimethyl phthalate | ABCC3 FLT1 GGNBP2 HIP1 DRD1 MYO5B POLRMT PSMC5 NEK9 ITPR1 JARID2 PTPN6 TLN1 NCAPD2 KIF14 UGT3A2 CDK1 USP39 MUC5AC KIF11 DNTT | 1.68e-07 | 714 | 176 | 21 | ctd:C024629 |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A | ATP6V1A CHMP1B NR4A2 RRM1 NEK9 ITPR1 TMEM156 PTPN11 MACF1 CDK1 | 1.77e-06 | 184 | 176 | 10 | 1772_DN |
| Drug | SC-560; Down 200; 10uM; PC3; HT_HG-U133A | SPTAN1 MINK1 CEP290 TBC1D8B NCDN RHO EIF5 CFAP44 PCDH1 CCDC40 | 3.42e-06 | 198 | 176 | 10 | 6865_DN |
| Drug | salicylideneaniline | 4.49e-06 | 5 | 176 | 3 | ctd:C510217 | |
| Drug | Schiff Bases | 4.49e-06 | 5 | 176 | 3 | ctd:D012545 | |
| Drug | oxovanadium IV | 4.49e-06 | 5 | 176 | 3 | ctd:C075743 | |
| Drug | oxindole | 6.05e-06 | 34 | 176 | 5 | CID000321710 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.01e-05 | 177 | 176 | 9 | 4164_UP | |
| Drug | 3-methoxytyramine | 1.06e-05 | 38 | 176 | 5 | CID000001669 | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.10e-05 | 194 | 176 | 9 | 5954_UP | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 6328_UP | |
| Drug | valrocemide | 2.47e-05 | 8 | 176 | 3 | CID006918293 | |
| Drug | 6-mercaptopurine | 2.54e-05 | 75 | 176 | 6 | CID000667490 | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.67e-05 | 200 | 176 | 9 | 1526_UP | |
| Drug | Gp35 | 3.84e-05 | 25 | 176 | 4 | CID003002995 | |
| Drug | G-G-G | 4.17e-05 | 50 | 176 | 5 | CID000448212 | |
| Drug | plakin | 4.22e-05 | 82 | 176 | 6 | CID000018752 | |
| Disease | Intellectual Disability | PUS3 NR4A2 CHD8 CHD3 KCNQ5 SCN8A PACS2 MACF1 ALDH4A1 GNAS PYCR2 GOT2 | 1.69e-05 | 447 | 176 | 12 | C3714756 |
| Disease | Colorectal Carcinoma | ABCC3 DNAH3 CCDC9B OBSCN NR4A2 PSMC5 NCDN KCNQ5 RHPN2 LRP1 UGT3A2 GNAS DMD ABCC2 SDCBP2 | 2.22e-05 | 702 | 176 | 15 | C0009402 |
| Disease | Noonan syndrome 1 (implicated_via_orthology) | 3.54e-05 | 2 | 176 | 2 | DOID:0060578 (implicated_via_orthology) | |
| Disease | Disorder of eye | 4.31e-05 | 212 | 176 | 8 | C0015397 | |
| Disease | Schizophrenia | DRD1 COMT MYO5B NR4A2 LMOD2 KMO ADAMTS12 JARID2 PTPN6 EIF5 LRP1 SEPTIN11 TAAR1 GNAL GNAS NOS1AP | 8.41e-05 | 883 | 176 | 16 | C0036341 |
| Disease | Drug-induced paranoid state | 1.06e-04 | 3 | 176 | 2 | C1306067 | |
| Disease | Tremor, Rubral | 1.10e-04 | 16 | 176 | 3 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.10e-04 | 16 | 176 | 3 | C0750937 | |
| Disease | Ataxia, Motor | 1.10e-04 | 16 | 176 | 3 | C0278161 | |
| Disease | Ataxia, Sensory | 1.10e-04 | 16 | 176 | 3 | C0240991 | |
| Disease | Abnormal coordination | 1.10e-04 | 16 | 176 | 3 | C0520966 | |
| Disease | Ataxia, Truncal | 1.10e-04 | 16 | 176 | 3 | C0427190 | |
| Disease | Bipolar Disorder | DRD1 COMT CHMP1B PCLO NR4A2 ADCY3 CNTN6 ITPR1 SCN8A SEPTIN11 GNAL | 1.47e-04 | 477 | 176 | 11 | C0005586 |
| Disease | kynurenate measurement | 2.11e-04 | 4 | 176 | 2 | EFO_0800141 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) measurement | 2.11e-04 | 4 | 176 | 2 | EFO_0800411 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.21e-04 | 20 | 176 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | NPC1 PDS5B FLT1 DRD1 UBD PCLO FABP1 JARID2 PTPN11 LIPC SEPTIN14 AHCY RP1 ABCC2 NOS1AP | 2.38e-04 | 869 | 176 | 15 | EFO_0004735 |
| Disease | C-reactive protein measurement | NPC1 HIP1 MLEC UBE2Q1 PPP1R3B DPYSL5 MRPL33 GCKR ADCY3 FABP1 ITPR1 MICU1 PTPN2 DNAH17 FAM227A MACF1 MAP4K4 GCN1 | 3.36e-04 | 1206 | 176 | 18 | EFO_0004458 |
| Disease | Insulinogenic index measurement | 3.50e-04 | 5 | 176 | 2 | EFO_0009961 | |
| Disease | Aneuploidy | 3.50e-04 | 5 | 176 | 2 | C0002938 | |
| Disease | juvenile myelomonocytic leukemia (implicated_via_orthology) | 3.50e-04 | 5 | 176 | 2 | DOID:0050458 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (15:0_18:1) in blood serum | 3.50e-04 | 5 | 176 | 2 | OBA_2045064 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 3.85e-04 | 24 | 176 | 3 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | alkaline phosphatase measurement | UBD PPP1R3B MINK1 CHD3 GCKR COLEC10 FABP1 ITPR1 PTPN11 LIPC RHPN2 EIF2B2 FAM227A MACF1 RP1 UTRN | 4.03e-04 | 1015 | 176 | 16 | EFO_0004533 |
| Disease | Ataxia | 4.36e-04 | 25 | 176 | 3 | C0004134 | |
| Disease | Insulin Resistance | 4.60e-04 | 60 | 176 | 4 | C0021655 | |
| Disease | Insulin Sensitivity | 4.60e-04 | 60 | 176 | 4 | C0920563 | |
| Disease | kidney disease (is_implicated_in) | 5.22e-04 | 6 | 176 | 2 | DOID:557 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (16:0_18:1) in blood serum | 5.22e-04 | 6 | 176 | 2 | OBA_2045070 | |
| Disease | Cholestasis | 5.27e-04 | 110 | 176 | 5 | C0008370 | |
| Disease | Headache | 5.88e-04 | 64 | 176 | 4 | HP_0002315 | |
| Disease | urinary metabolite measurement | 7.00e-04 | 245 | 176 | 7 | EFO_0005116 | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 7.28e-04 | 7 | 176 | 2 | EFO_0800245 | |
| Disease | focal segmental glomerulosclerosis (implicated_via_orthology) | 7.28e-04 | 7 | 176 | 2 | DOID:1312 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 7.28e-04 | 7 | 176 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | temporal horn of lateral ventricle volume measurement | 9.17e-04 | 72 | 176 | 4 | EFO_0010333 | |
| Disease | Chromosomal Instability | 9.67e-04 | 8 | 176 | 2 | C1257806 | |
| Disease | X-17676 measurement | 9.67e-04 | 8 | 176 | 2 | EFO_0800785 | |
| Disease | Retinitis pigmentosa | 1.02e-03 | 74 | 176 | 4 | cv:C0035334 | |
| Disease | Amphetamine-Related Disorders | 1.07e-03 | 75 | 176 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 1.07e-03 | 75 | 176 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 1.07e-03 | 75 | 176 | 4 | C0236804 | |
| Disease | serum gamma-glutamyl transferase measurement | MLEC MYO9A GCKR COLEC10 RYR2 ITPR1 MICU1 RHPN2 TLN1 EIF5 FAM227A RP1 ABCC2 GCN1 | 1.22e-03 | 914 | 176 | 14 | EFO_0004532 |
| Disease | cognitive disorder (is_implicated_in) | 1.24e-03 | 9 | 176 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.29e-03 | 36 | 176 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.40e-03 | 37 | 176 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | bilirubin measurement | 1.41e-03 | 442 | 176 | 9 | EFO_0004570 | |
| Disease | glycine measurement | 1.41e-03 | 137 | 176 | 5 | EFO_0009767 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 1.54e-03 | 10 | 176 | 2 | EFO_0800608 | |
| Disease | level of phosphatidylcholine | 1.54e-03 | 10 | 176 | 2 | OBA_2040179 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | blood urea nitrogen measurement | 1.64e-03 | 452 | 176 | 9 | EFO_0004741 | |
| Disease | serum metabolite measurement | MAGEL2 COMT MLEC CKAP5 GCKR KMO SIAE LRPPRC LIPC DNAH17 TAAR1 ABCC2 D2HGDH GOT2 | 1.67e-03 | 945 | 176 | 14 | EFO_0005653 |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.88e-03 | 11 | 176 | 2 | EFO_0800269 | |
| Disease | 1-stearoyl-GPE (18:0) measurement | 1.88e-03 | 11 | 176 | 2 | EFO_0800227 | |
| Disease | Macrocephaly | 1.88e-03 | 11 | 176 | 2 | C0221355 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.88e-03 | 11 | 176 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | placenta growth factor measurement | 1.88e-03 | 11 | 176 | 2 | EFO_0010626 | |
| Disease | Tumoral calcinosis | 2.02e-03 | 42 | 176 | 3 | C0263628 | |
| Disease | Calcinosis | 2.02e-03 | 42 | 176 | 3 | C0006663 | |
| Disease | Microcalcification | 2.02e-03 | 42 | 176 | 3 | C0521174 | |
| Disease | DNA methylation | SCFD2 HIP1 MRPL33 GCKR FABP12 CNTN6 PIK3CG MROH2B GNAL ATP2B4 NOS1AP | 2.03e-03 | 656 | 176 | 11 | GO_0006306 |
| Disease | metabolite measurement | 2.05e-03 | 560 | 176 | 10 | EFO_0004725 | |
| Disease | glucose measurement | 2.10e-03 | 380 | 176 | 8 | EFO_0004468 | |
| Disease | gait measurement | 2.10e-03 | 150 | 176 | 5 | EFO_0007680 | |
| Disease | Gastrointestinal Diseases | 2.24e-03 | 12 | 176 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 2.24e-03 | 12 | 176 | 2 | C0559031 | |
| Disease | Cholera Infantum | 2.24e-03 | 12 | 176 | 2 | C1565321 | |
| Disease | level of Phosphatidylcholine (14:0_18:1) in blood serum | 2.24e-03 | 12 | 176 | 2 | OBA_2045062 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 2.24e-03 | 12 | 176 | 2 | OBA_2045074 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.56e-03 | 157 | 176 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 2.64e-03 | 13 | 176 | 2 | C0750905 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.64e-03 | 13 | 176 | 2 | EFO_0800474 | |
| Disease | X-24588 measurement | 2.64e-03 | 13 | 176 | 2 | EFO_0800898 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.64e-03 | 13 | 176 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Amino Acid Metabolism, Inborn Errors | 2.64e-03 | 13 | 176 | 2 | C0002514 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.64e-03 | 13 | 176 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 2.64e-03 | 13 | 176 | 2 | OBA_2045082 | |
| Disease | phosphoglycerides measurement | 2.96e-03 | 48 | 176 | 3 | EFO_0022291 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.96e-03 | 99 | 176 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | UBD PPP1R3B OBSCN GCKR ITPR1 ADAMTS12 PTPN11 LIPC SEPTIN14 OSBPL5 ABCC2 GCN1 GOT2 | 3.13e-03 | 904 | 176 | 13 | EFO_0004736 |
| Disease | pancreatic cancer (is_marker_for) | 3.19e-03 | 101 | 176 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.33e-03 | 50 | 176 | 3 | EFO_0022247 | |
| Disease | Major Depressive Disorder | 3.48e-03 | 243 | 176 | 6 | C1269683 | |
| Disease | body mass index, fasting blood glucose measurement | 3.52e-03 | 51 | 176 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | YKL40 measurement | 3.53e-03 | 15 | 176 | 2 | EFO_0004869 | |
| Disease | Liver carcinoma | 3.53e-03 | 507 | 176 | 9 | C2239176 | |
| Disease | Retinitis Pigmentosa | 3.54e-03 | 104 | 176 | 4 | C0035334 | |
| Disease | non-high density lipoprotein cholesterol measurement | NPC1 GGNBP2 COMT NPEPPS MYO1H GCKR ARCN1 FABP1 LIPC TAMM41 RP1 | 3.82e-03 | 713 | 176 | 11 | EFO_0005689 |
| Disease | Spondyloepiphyseal Dysplasia | 4.02e-03 | 16 | 176 | 2 | C0038015 | |
| Disease | maximal oxygen uptake measurement, response to exercise | 4.02e-03 | 16 | 176 | 2 | EFO_0004887, EFO_0007768 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.02e-03 | 16 | 176 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.02e-03 | 16 | 176 | 2 | C4551479 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 4.02e-03 | 16 | 176 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | Schwartz-Jampel Syndrome | 4.02e-03 | 16 | 176 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.02e-03 | 16 | 176 | 2 | C0025237 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 4.02e-03 | 16 | 176 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | sex interaction measurement, inflammatory bowel disease | 4.36e-03 | 55 | 176 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.36e-03 | 55 | 176 | 3 | C0079744 | |
| Disease | phospholipids in medium HDL measurement | 4.36e-03 | 55 | 176 | 3 | EFO_0022295 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKNIKVIMATNRIDI | 286 | P62195 | |
| VSLVARNTMVKTVRK | 26 | F5H4B4 | |
| QAMVRSAGKLVLIDK | 1126 | Q9HCK8 | |
| EIITQSKLVIMVGQK | 701 | Q9NQ75 | |
| TVARKSGMVSESQKV | 726 | Q4VNC1 | |
| RGNIMKISDVKSRVQ | 1706 | Q7Z2Y8 | |
| KQAKVSTVMDTVGRR | 456 | Q9H845 | |
| GKLTMRDEQSAVIVV | 4206 | Q8WXG9 | |
| AEILAKTMVGQGKTV | 141 | P30038 | |
| KTMVGQGKTVIQAEI | 146 | P30038 | |
| SMKFVKNVIAGIRET | 141 | Q9Y6Z7 | |
| TRKLVDGKMVVESTV | 106 | A6NFH5 | |
| KSEVEMVIKTGRQIV | 1516 | P11532 | |
| RETKVLKTLSVIMGV | 266 | P21728 | |
| KTGVFVRTLQMDKVE | 1106 | Q8WUJ3 | |
| TEMINGHKVTTKRIV | 186 | Q8NHS0 | |
| ETVRQLMISKFGRVV | 1696 | Q96MT7 | |
| AIAKCKQAGITVRMV | 681 | P23634 | |
| HGEKKRTVLCIQTMV | 901 | P58397 | |
| KGAVAMAETLKTLRQ | 251 | P46060 | |
| SVKAIFSKVMVITRN | 521 | Q9NTI5 | |
| GIVESIQIMKEGKAT | 181 | Q8TDF5 | |
| ATTQKAEKEVTRMVI | 241 | P08100 | |
| TKAVVMLNRIVEKES | 106 | P17706 | |
| KRASTVGEIVNLMSV | 401 | O15438 | |
| GMVKEVVRTDSLKGR | 331 | P22736 | |
| AARVQTAVTMGKVTK | 76 | Q7LBR1 | |
| MRVAGAAKLVVAVAV | 1 | Q92520 | |
| KTGQLAAIKVMDVTE | 46 | O95819 | |
| REKIEKASQVVFMSG | 371 | Q15058 | |
| KRIIIKGVDAETMHT | 111 | Q8WZ60 | |
| QAKVPVQRSEMVKVI | 1036 | Q9UJ55 | |
| KVRELVDKATNVVMN | 6 | Q14677 | |
| KVQLVSVMKEAIGAV | 361 | Q9UBB6 | |
| VKIVQGIRAMEVDSS | 261 | Q8TD19 | |
| QLRKIKSMERVQGVS | 41 | O43187 | |
| RKSFEMTVEKVQGIS | 336 | Q9H3C7 | |
| RMKVAQQEIKATVTV | 1871 | Q14643 | |
| RSTGEMVAIKILKND | 31 | Q8NE63 | |
| ETIKQLQERAGVKMV | 206 | Q96AE4 | |
| MSIRKGKLSVQGEVS | 171 | Q14165 | |
| RVMSGKLTVQEEQIV | 406 | P52732 | |
| VIEVAQMKGENRKTL | 3981 | Q07954 | |
| LVENMVTVGKTILER | 106 | Q9NQE9 | |
| SMLGRVVKVEKQVQS | 601 | Q9NR82 | |
| MGRVVKVEKQVQSIE | 616 | P56696 | |
| MEAIRGSSIKQLKRV | 526 | Q6P5Q4 | |
| VTMENKAEGKRIVSE | 166 | Q6ZUT6 | |
| RVAISVEKKTVTMIV | 166 | P12107 | |
| VVGAVRQEKRMSKAT | 611 | Q9Y6F6 | |
| RKASKVMVVLTDGGI | 301 | P38570 | |
| LDKVTMQQVARTVAK | 391 | Q9BPX6 | |
| TEAKTQVMGEIKIAL | 5001 | Q9Y6V0 | |
| GAKTTQIRIHVVKMF | 296 | Q9UKL2 | |
| PKSARAQVVVTVKDM | 366 | Q08174 | |
| VQKLKAVAGVMITAS | 161 | Q6PCE3 | |
| KDVVAIIMAVNKVDG | 186 | P16499 | |
| VGKEVLAVIMAVNKV | 186 | P51160 | |
| IAVKGLTNSKSAVMR | 436 | Q96J66 | |
| KTIRVKAGETQQRMT | 451 | P11150 | |
| AVTRVIQALAMKGDV | 1141 | P42704 | |
| KRGIIEMADLVAVTK | 276 | Q8IVH4 | |
| FKLGVKVRTAIMASV | 386 | Q92887 | |
| ALDGLKQVMAIKSRV | 2061 | Q92616 | |
| VLMKVDGVVIQLTKG | 136 | P98088 | |
| RVIVMTTKEVERGKS | 351 | Q06124 | |
| EKELISVVIAVKMQG | 56 | Q86VP3 | |
| SVVIAVKMQGSKRIL | 61 | Q86VP3 | |
| EMNERTNVGILKVVK | 321 | Q02413 | |
| RKVKEIVMVTQGPSE | 311 | Q8ND30 | |
| IAKAKVVAEQMSRLT | 1221 | Q9UPN3 | |
| VSYGRIIVTVVKMKS | 216 | Q9H210 | |
| IILTIHKMNSVEGRK | 221 | Q8NGZ9 | |
| TTMVQVAGKVQEVLK | 81 | Q14397 | |
| GESGKSTIVKQMRIL | 51 | P38405 | |
| KKARLIASNVTETMG | 1056 | O15118 | |
| VGITKRLKTMEVLEG | 2736 | Q5VST9 | |
| RMVDFAGVKDKVTLV | 151 | P21964 | |
| QRKMRVTGVITQGAK | 221 | O43854 | |
| KVVGKDTNVMLVALA | 326 | Q14008 | |
| GIKTVIVNMVDVAKA | 31 | P55010 | |
| MDSSVIQRKKVAVIG | 1 | O15229 | |
| QKALVAKVSQREEMV | 1201 | P54132 | |
| EVRNIVDKAVKESGM | 1396 | Q9UFH2 | |
| VVAKMIVAKVESSQA | 1766 | Q9UFH2 | |
| IVEKMQTAARTQGEK | 2526 | Q8TD57 | |
| QRKLKTTGMTVDQVL | 1961 | O15078 | |
| QQVLTRIGVMSLVKK | 1486 | Q12873 | |
| VVKISVHMGRVSLKQ | 181 | Q7Z7M9 | |
| RVMTQVVKKAETERI | 416 | Q4G0X9 | |
| SGKSTIVKQMRILHV | 51 | P63092 | |
| VREKTKTGVDMRVGV | 401 | O60266 | |
| VTVREIVVGSNMDKI | 486 | Q9UQ88 | |
| KQVVIKEGDMLRLTS | 131 | Q9UHN6 | |
| MIGKIRVSGNVTTKN | 851 | Q9UQ52 | |
| GMVERKKGAIVTISS | 191 | Q3SXM5 | |
| MSRVNKVIIGTKTIL | 226 | P49770 | |
| KVSIMVSVDGVKVIL | 71 | O75052 | |
| LRACMEKGVKVVAVN | 91 | O14556 | |
| DGIKRATDVMIAGKV | 201 | P23526 | |
| SVDVKSVRMGSIQRK | 376 | Q92736 | |
| LEGFITRKVVKQTVM | 981 | O00411 | |
| TRKVVKQTVMTVVYG | 986 | O00411 | |
| ARAGIISTVEVLKVM | 626 | P55786 | |
| KAGKAIVSRQFVEMT | 11 | P48444 | |
| LVTDGTMATDQRKVK | 366 | Q8N465 | |
| VIAAAKMQGKVVLAE | 256 | Q9BPU6 | |
| RIIRAELKSTQGMTK | 231 | Q86XI6 | |
| LDNGTVIMDVKGIKV | 1286 | Q16363 | |
| KQVSKVNGVTRMSSL | 301 | Q92833 | |
| VVIMADSLKIRGTLK | 126 | Q9H0X9 | |
| RINTKGRITKEMIVQ | 701 | P56715 | |
| KTGQLAAIKVMDVTE | 46 | Q8N4C8 | |
| QKCLAVGMVKEVVRT | 321 | P43354 | |
| VGMVKEVVRTDSLKG | 326 | P43354 | |
| GMVKEVVRTDSLKGR | 356 | Q92570 | |
| GIIKGMKVELSTVNV | 101 | Q92665 | |
| VGDVEEINKTVSRMK | 2256 | P46939 | |
| IGRAVEIGVKKFMIT | 36 | Q6P1N9 | |
| IKQTSAFVEGVKMRT | 396 | Q9BZE2 | |
| AVVGSTDEVKVGKRM | 246 | Q6ZU15 | |
| VVGSTEEVKIGNKMA | 236 | Q9NVA2 | |
| KKTIVTDVFQGSMRI | 341 | Q53GS9 | |
| VVFILEKKMGTTRRA | 36 | P04053 | |
| KVTEAEKVFMVARGL | 101 | Q96ER9 | |
| VAIRTAKGEKFVMQE | 326 | P30101 | |
| EIGQVVMTITKLTQK | 751 | Q9NTG1 | |
| AGESGKSTIVKQMRI | 691 | Q5JWF2 | |
| KMLLVGSRKAAEQVI | 621 | O00291 | |
| IFVVTGRKEDVAMAK | 276 | Q5U5Q3 | |
| LRQGQETIMKKVTSV | 61 | Q9HAT2 | |
| GSKRIGMVIHQVETK | 221 | Q99865 | |
| MLVLGNKVKAVGEVT | 2616 | O75592 | |
| RKMGVNLTRSNKETV | 46 | Q96C36 | |
| GKVEMTIIAAKEGTV | 246 | Q9H1D9 | |
| VGGVTVSEVKMVKDL | 631 | Q8WU76 | |
| ERTVKIVMGDLSTKV | 356 | Q7Z745 | |
| MLVKVAQEAAKVGEV | 306 | Q8IUC4 | |
| LETMTGEKVKTVVQL | 71 | P07148 | |
| KKIMEILATAGNVVT | 246 | Q9H190 | |
| IIGMRTQLVSNLKKE | 351 | P00505 | |
| TGQVVAMKKIRLESE | 26 | P06493 | |
| MKSIVGEIVREIGQK | 271 | Q15021 | |
| LAAIKMQTKVIERVS | 1196 | O75122 | |
| IGMIEIVKDATTIAK | 876 | P48736 | |
| QTSKVLIRRGSMEVK | 116 | Q8N614 | |
| TITAVVKTEGRMKLY | 61 | P25874 | |
| MGKLAVIRGVTTKEL | 211 | Q1ZZU3 | |
| KVQGLVISQMLRKSV | 581 | Q9UID3 | |
| SVAQVKAMIETKTGI | 111 | O15205 | |
| KMVADTISRTEKQVV | 571 | P09327 | |
| LMHRTLKNIVEGKTV | 96 | Q9HA47 | |
| IVNSKAISREVKAMA | 51 | Q9Y572 | |
| SKSKNILVRMVSEAG | 11 | O75394 | |
| GVSMFRTKKTRDLVV | 471 | Q0IIM8 | |
| EGKKARVMATIGVTR | 376 | Q9ULR3 | |
| ISQKTVLKMAAERGA | 686 | P23921 | |
| QVRPMSDKVAGKVTR | 836 | Q7Z4S6 | |
| MVALSLKISIGNVVK | 1 | Q9Y490 | |
| AKAIAVTVQEMVTKS | 1861 | Q9Y490 | |
| TKEAGSVSLRMKQVE | 1056 | Q13813 | |
| KMLTSLERDKVVGQI | 241 | Q8N0X2 | |
| TIANARKLIDEMVGK | 246 | O75695 | |
| TTFIEMGKVKDIVIN | 111 | Q14442 | |
| ITATEIRNQVKKEMI | 611 | Q9HBX9 | |
| VGALIQSVKKLSDVM | 241 | Q9UQD0 | |
| KVESIMKRTALVANT | 301 | P38606 | |
| ERKAVKTLGIVMGVF | 246 | Q96RJ0 | |
| MLVKVAQEAAKVGEV | 221 | A8MT19 | |
| IIGEKANMTVTRIKE | 1006 | Q86WI1 | |
| TRVIVKTAGNQKDFM | 31 | Q8IYU4 | |
| RMVVGEDKTKVLNIV | 191 | Q96BW9 | |
| MVLISGKAAKIASRQ | 471 | P49190 | |
| VIVMTTREVEKGRNK | 346 | P29350 | |
| KRTMVKTSVLVVQFV | 171 | Q9ULQ1 | |
| ERQIVVGICSMAKKS | 41 | O43314 | |
| ENMVRVEAKKFGVSI | 396 | Q3SY77 | |
| IIEGKNKMASTLVVA | 511 | P17948 | |
| IGRIAMVTKQVTDAE | 816 | O60293 | |
| TKIAVTKCGNVMLRQ | 876 | Q8TEY7 | |
| MQISATLVKGKARVQ | 371 | Q7Z7E8 | |
| MQQKVVTSEIFRGRK | 841 | Q8N1T3 | |
| ADKFRTATIMIQKTV | 761 | Q9ULV0 | |
| TMSQGEITKLAVRQK | 1731 | B2RTY4 |